EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement

Xiaofeng Zhang iD, Ling Zhou, Weihao Liang, Xiao Cheng, Qinjun He, Hui Li, Wenfan Luo iD, Jing Huang, Junying Li, Weibin Wang, Minghan Tu, Haiyu Wang und 6 weitere

Liver International · 2025

DOI: 10.1111/liv.16241 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Liver International, 2025. Verfasst von Xiaofeng Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Hypertension, Portal, Spleen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Science and Technology Major Project, National Natural Science Foundation of China, Clinical Research Program of Nanfang Hospital, Southern Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims The Baveno VII consensus recommends spleen stiffness measurement (SSM) for the detection of clinically significant portal hypertension (CSPH) in patients with compensated advanced chronic liver disease (cACLD). We aimed to evaluate the performance of SSM‐based algorithms.

Methods

Consecutive cACLD individuals who underwent hepatic venous pressure gradient measurement, liver stiffness measurement (LSM), and SSM measured with the dedicated 100‐Hz probe by vibration‐controlled transient elastography were prospectively enrolled.

Results

From July 2021 to August 2024, a total of 395 patients were screened, and 185 cACLD cases were enrolled, of which 101 patients had CSPH. An SSM > 50 kPa demonstrated a positive predictive value (PPV) of 98.0% and a specificity of 98.8% for ruling in CSPH, correctly identifying 47.5% (48/101) of CSPH cases. Sensitivity analysis revealed that in 60 patients with aetiology removal or suppression, SSM > 50 kPa achieved both a PPV and specificity of 100%. Among the 125 patients with ongoing aetiologies, the PPV and specificity were 96.4% and 98.3%, respectively. Across HBV (with or without viral suppression) and non‐HBV subgroups, the PPV and specificity consistently exceeded 90%. In decision curve analysis, SSM > 50 kPa provided the highest net benefit compared with other elastography‐based algorithms when threshold probabilities exceeded 0.8.

Conclusions

We prospectively validated that SSM > 50 kPa, measured using the spleen‐dedicated probe, is sufficient for identifying CSPH in individuals with cACLD. Trial Registration NCT04820166

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Elasticity Imaging TechniquesHypertension, PortalSpleenAdultAgedFemaleHumansMaleMiddle AgedAlgorithmsChronic DiseaseLiverPredictive Value of TestsProspective StudiesSensitivity and Specificity

Stichwörter der Autor:innen

Baveno VIIclinically significant portal hypertensionliver stiffness measurementspleen stiffness measurement

Autor:innen und Institutionen

  • Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Hepatology, Zengcheng Branch, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Infectious Diseases, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
  • Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China.
  • State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China.

ORCID-Profile: Xiaofeng Zhang, Wenfan Luo, Jinjun Chen

Förderung

  • National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Clinical Research Program of Nanfang Hospital, Southern Medical University
  • Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education
  • Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program

Zitieren

APA

Zhang, X., Zhou, L., Liang, W., Cheng, X., He, Q., Li, H., Luo, W., Huang, J., Li, J., Wang, W., Tu, M., Wang, H., Ou, P., Wen, B., Xiao, L., Zhou, D., Wong, V. W., & Chen, J. (2025). Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement. Liver International. https://doi.org/10.1111/liv.16241

Vancouver

Zhang X, Zhou L, Liang W, Cheng X, He Q, Li H, et al. Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement. Liver International. 2025. doi:10.1111/liv.16241

BibTeX
@article{Zhang2025,
  author = {Zhang, Xiaofeng and Zhou, Ling and Liang, Weihao and Cheng, Xiao and He, Qinjun and Li, Hui and Luo, Wenfan and Huang, Jing and Li, Junying and Wang, Weibin and Tu, Minghan and Wang, Haiyu and Ou, Pengcheng and Wen, Biao and Xiao, Lushan and Zhou, Damei and Wong, Vincent Wai-Sun and Chen, Jinjun},
  title = {Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16241}
}
Kostenlos starten →